You are here : Home > CIBEST Team > Research topics of the team > Improving Human health > Copper chelators and Wilson’s Disease

Copper chelators and Wilson’s Disease

Published on 2 November 2022
Pascale Delangle

A number of pathological disorders are associated with a metal overload. The team is actively involved in the design and the synthesis of specific copper chelators for the treatment of Wilson’s disease.